
Sudeep Pharma Ltd is Rated Hold by MarketsMOJO
2026-11-20 10:11:27Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read More
Sudeep Pharma Ltd is Rated Hold by MarketsMOJO
2026-11-09 10:10:56Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the latest insights into its performance and outlook.
Read More
Sudeep Pharma Ltd Surges 7.44% to Day's High of Rs 1189.65 — Outperforms Sector by 4.55 Percentage Points
2026-11-05 14:32:14The Sensex advanced 2.53% on 5 Nov 2026, yet Sudeep Pharma Ltd outpaced the broader market with a 7.44% gain, reaching an intraday high of Rs 1189.65. This 4.55-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum shift rather than a mere market tailwind.
Read More
Sudeep Pharma Ltd is Rated Hold by MarketsMOJO
2026-10-29 10:12:21Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 October 2026, providing investors with the latest insights into its performance and outlook.
Read More
Sudeep Pharma Ltd Surges 7.84% to Day's High of Rs 1102 — Outperforms Sector by 6.95 Percentage Points
2026-10-28 13:03:41The Sensex edged lower by 0.11% on 28 Oct 2026, while Sudeep Pharma Ltd surged 7.84%, touching an intraday high of Rs 1102. This 6.95-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.
Read More
Sudeep Pharma Ltd is Rated Hold by MarketsMOJO
2026-10-18 10:10:42Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 October 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read More
Sudeep Pharma Ltd Hits Intraday Low Amid Price Pressure on 12 Oct 2026
2026-10-12 11:16:33Sudeep Pharma Ltd experienced a notable decline today, hitting its intraday low as selling pressure intensified amid broader market weakness. The stock closed with a significant loss of 7.54%, underperforming its sector and the benchmark Sensex, reflecting immediate pressures on its price momentum.
Read More
Sudeep Pharma Ltd is Rated Hold by MarketsMOJO
2026-10-07 10:10:52Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Sudeep Pharma Ltd Locks at Upper Circuit With 4.36% Gain — Buyers Queue, Sellers Absent
2026-09-29 13:00:15At Rs 1,188.4, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Sudeep Pharma Ltd locked at its upper circuit of 4.36% on 29 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreIntimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 Regarding Direction Issued By The Gujarat Pollution Control Board
19-Nov-2026 | Source : BSEDirections Issued by the Gujarat Pollution Control Board
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
03-Nov-2026 | Source : BSESubmission of Transcript for the Earnings call held on 29.10.2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29-Oct-2026 | Source : BSESubmission of Audio Recording of the Earnings call held on 29th October 2026
Corporate Actions
No Upcoming Board Meetings
Sudeep Pharma Ltd has declared 150% dividend, ex-date: 23 Jul 26
No Splits history available
No Bonus history available
No Rights history available